OSE Oncology services Europe S.a.r.l receives reinforcement in the management by Dr. Christine Unger

(openPR) - the OSE, a Full service CRO within the range clinical development, specialized in Onkologie, got itself Dr. Christine Unger as Chief operating Officer also in the boat. Mrs. Dr. Unger transfers the operational management of the OSE, in order to be able to make the development of the society to Europe purposefully.

Last Dr.Unger was active with the Xantos Biomedicine AG as managers for Business development, where she took both the responsibility for the public work and for the Neukundenakquise of the service business of the Xantos AG. Before Dr. Unger led several Onkologieprojekte for the identification and validating of new targets as well as the group of protein express ions of the Xerion Pharmaceuticals AG.

The managing director of the OSE Oncology services Europe, Dr. Wolfgang Beier over the increase: “We are pleased much that we could win Mrs. Dr. Unger for us. There is an increasing need of the Pharma and above all the Biotechindustrie at regional external capacities. This is in the clinical research particularly for the development phases I - IIIa the case. For this development section of a substance one needs national and internationally identified and scientifically accepted test centers with appropriate expert's assessment in the clinical research. By the personnel reinforcement in the management we can develop this expert's assessment further particularly within the biotechnology range now.”

Contact:

OSE Oncology services Europe S.a.r.l.
Dr. Christine Unger
Cuvilliésstr. 14 A
D-81677 Munich
Tel.: 0 89 - 89 52 18-0
Fax: 0 89 - 89 52 18-20
sandra.retzer@os-europe.com
www.os-europe.com

The OSE Oncology services Europe belongs into the group of the technically specialized institutes for investigation on assignments and is identified in German and Europe as qualitatively high-quality Dienstleister in the range of the Onkologie. Beside the classical CRO business the OSE transfers also strategic Consultingprojekte in the range Clinical Drug development and Licensing out, which particularly for small and medium-size Pharma - and Biotechunternehmen from interest is.

Dieser Artikel wurde veröffentlicht auf
OpenPR - http://openpr.de/news/120040/OSE-Oncology-Services-Europe-S-a-r-l-erhaelt-Verstaerkung-in-der-Geschaeftsleitung-durch-Dr-Christine-Unger.html